Could a common diabetes pill make veterans' arteries younger?
NCT ID NCT06745063
First seen Nov 15, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study tests whether empagliflozin, a drug used for diabetes, can improve artery stiffness in 50 veterans with obesity but without diabetes. Participants will take either the drug or a placebo for 12 weeks, and researchers will measure changes in arterial health using a non-invasive test. The goal is to see if this treatment can reduce cardiovascular risk in this population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Harry S. Truman Memorial, Columbia, MO
RECRUITINGColumbia, Missouri, 65201-5275, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.